Ewch i’r prif gynnwys

Population medicine

Mae'r cynnwys hwn ar gael yn Saesneg yn unig.

We are committed to delivering research that makes a difference to people’s lives and has an impact.​

We do this through our research into the combination of social, environmental and biological risk factors and interventions for improving health, wellbeing and patient care.​

The population health challenge in Wales is characterised by persistent inequality gaps in health and wellbeing, increasingly complex multi-morbidity patterns and a high prevalence of economic, environmental, social and lifestyle related health risk factors such as smoking, obesity and alcohol related harm.​

Overall, people are living longer but many are living with more than one health condition.​

With increasing pressure on the healthcare system and finite resources to meet these needs we must re-think how we engage the public to create healthy environments, improve and sustain health and well-being and ensure that the provision of safe, high quality healthcare services is based on the highest quality of evidence.​

Our research involves:​

  • Large-scale epidemiological studies to understand the social, environmental and biological risk factors for diseases, and outcomes associated with healthcare use ​
  • Developing, testing and implementing clinical diagnostic, therapeutic and complex behaviour change interventions to improve health and healthcare in the community and NHS settings.​

Public and patient involvement in research is integral to ensuring our research is relevant to and has a positive impact on the health and wellbeing of the people of Wales and beyond. Find out more about public and patient engagement within the School of Medicine.


Medical statistics and epidemiology​

Medical statistics and epidemiology

Our statistical methodological work is particularly focused on longitudinal data, (informatively) irregularly-collected data and causal inference.

 Screening, prevention and early diagnosis​

Screening, prevention and early diagnosis​

Increasing understanding of the influences on cancer risk and prevention, early symptomatic diagnosis, and uptake and technology application in screening (including colorectal and lung).​

Healthcare and behaviour interventions

Healthcare and behaviour interventions

We develop and evaluate interventions that aim to improve health and wellbeing.​

We work across all four health areas, and have particular expertise in primary and community care settings, behavioural and complex interventions, and antimicrobial use and stewardship.

Child health and wellbeing​

Our research is aimed at developing and validating clinical prediction tools for identifying children at risk of child abuse or neglect.

Collaborative healthcare

 Collaborative healthcare​

Our work on collaborative healthcare draws on the approaches of patient centred care, patient empowerment and co-production in engaging patients and members of the public in health and healthcare.​

We focus on innovation, implementation and evaluation of interventions.​

Our priority areas are:​

  • Shared decision making and decision aids​
  • Self-management and health literacy​
  • Prudent healthcare

Quality improvement and patient safety

 Quality improvement and patient safety​

The field of patient safety is the coordinated effort to prevent harm, caused by the process of health care itself, from occurring to patients. ​

We aim to determine the frequency, burden and preventability of healthcare associated harm in primary and emergency care settings, and to develop and implement interventions to improve patient safety in priority areas.​


Dr Andrew Carson-Stevens
Dr Alison Cooper
Professor Adrian Edwards
Dr Michelle Edwards
Hayley Prout
Dr Huw Williams

Palliative and supportive care

 Palliative and supportive care​

We work towards solutions for ensuring understanding and maintaining the balance for patients with advanced cancer taking part in clinical trials. ​

The Marie Curie Palliative Care Research Centre leads the work of the palliative and supportive care theme.

We lead on innovative trial designs to allow greater access to participants receiving palliative and supportive care and develop support for cancer treatment decisions at key points of care including interventions for malignant bowel obstruction.


Elin Baddeley
Dr Anthony Byrne
Toby Dinnen
Dr Emily Harrop
Dr Ishrat Islam
Dr Kate Lifford
Dr Mirella Longo
Mala Mann
Fiona Morgan
Professor Annmarie Nelson
Alisha Newman
Professor Simon Noble
Cynthia Ochieng
Dr Rhiannon Phillips
Dr Stephanie Sivell
Dr Amanda Woodward